Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Novel Transcriptome Signature as a Potential Prognostic Biomarker for Anti-Angiogenic Therapy in Glioblastoma Multiforme

1 Mar 2021

Abstract excerpt

Glioblastoma multiforme (GBM) is the most common and devastating type of primary brain tumor, with a median survival time of only 15 months. Having a clinically applicable genetic biomarker would lead to a paradigm shift in precise diagnosis, personalized therapeutic decisions, and prognostic prediction for GBM. Radiogenomic profiling connecting radiological imaging features with molecular alterations will offer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Ferroptosis and cancer prognosis
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33804433
DOI: 10.3390/cancers13051013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of Novel Transcriptome Signature as a Potential Prognostic Biomarker for Anti-Angiogenic Therapy in Glioblastoma MultiformePMID 33804433Read ↗

SOCS3 is Related to Cell Proliferation in Neuronal Tissue: An Integrated Analysis of Bioinformatics and ExperimentsSemantic proximity Read ↗

Identification of Hypoxia Prognostic Signature in Glioblastoma Multiforme Based on Bulk and Single-Cell RNA-SeqSemantic proximity Read ↗

A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analysesSemantic proximity Read ↗

Angiogenesis-Related Gene Signature-Derived Risk Score for Glioblastoma: Prospects for Predicting Prognosis and Immune Heterogeneity in GlioblastomaSemantic proximity Read ↗

Molecular Pathogenesis and Emerging Treatment for Glioblastoma.Semantic proximity Read ↗

A prognostic matrix gene expression signature defines functional glioblastoma phenotypes and nichesSemantic proximity Read ↗

Identification of novel genes associated with diagnosis and prognosis in glioblastomaSemantic proximity Read ↗

Identification of new targets for glioblastoma therapy based on a DNA expression microarraySemantic proximity Read ↗

Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma MultiformeSemantic proximity Read ↗

A Novel Six-mRNA Signature Predicts Survival of Patients With Glioblastoma MultiformeSemantic proximity Read ↗

Fibronectin Type III Domain Containing 3B as a Potential Prognostic and Therapeutic Biomarker for GlioblastomaSemantic proximity Read ↗

Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary GlioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.